Volta Medical VX1 AI Software to be Featured at Heart Rhythm 2022 -  Company’s VX1 AI software for use in atrial fibrillation will be featured during several events at the Congress - MARSEILLE, France and PROVIDENCE, R.I., April 27, 2022 (GLOBE NEWSWIRE) -- Volta...

First U.S. patients with persistent cardiac arrythmias treated using Volta Medical’s artificial intelligence-based analysis Novel, FDA-cleared and CE-certified medical device is designed to help cardiologists identify cardiac abnormalities in patients undergoing ablation treatment for persistent, drug-resistant atrial...